Nyxoah (NYXH) Total Non-Current Liabilities (2020 - 2026)
Nyxoah (NYXH) posted quarterly Total Non-Current Liabilities of $24.2 million for Q1 2026, up 4.15% year-over-year from $23.2 million in Q1 2025, and up 1.99% quarter-over-quarter from $23.7 million in Q4 2025.
Nyxoah (NYXH) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Nyxoah's Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $24.2 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 4.15% year-over-year to $24.2 million; the TTM figure through Mar 2026 stood at $24.2 million (up 4.15% YoY), while the FY2025 annual figure was $23.7 million, down 6.0% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $24.2 million, up from $23.7 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $11.1 billion in Q3 2022, with the low at $11.1 million in Q4 2022.
- The 5-year median for Total Non-Current Liabilities is $23.2 million (2025), against an average of $756.3 million.
- Peak annual rise in Total Non-Current Liabilities reached 130.68% in 2023, while the deepest fall reached 99.89% in 2023.
- Nyxoah's Total Non-Current Liabilities stood at $11.1 million in 2022, then grew by 13.81% to $12.6 million in 2023, then surged by 100.66% to $25.2 million in 2024, then retreated by 6.0% to $23.7 million in 2025, then grew by 1.99% to $24.2 million in 2026.
- Business Quant data shows NYXH's Total Non-Current Liabilities at $24.2 million in Q1 2026, $23.7 million in Q4 2025, and $25.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Nyxoah | 90.94 Mn | 90.94 Mn | 5.33 Mn | 44.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.28 Mn |
| Mar 31, 2026 | 24.20 Mn |
| Dec 31, 2025 | 23.73 Mn |
| Jun 30, 2025 | 25.05 Mn |
| Mar 31, 2025 | 23.23 Mn |
| Dec 31, 2024 | 25.24 Mn |
| Sep 30, 2024 | 24.42 Mn |
| Jun 30, 2024 | 12.60 Mn |
| Mar 31, 2024 | 12.87 Mn |
| Dec 31, 2023 | 12.58 Mn |
| Sep 30, 2023 | 12.63 Mn |
| Jun 30, 2023 | 12.63 Mn |
| Mar 31, 2023 | 27.75 Mn |
| Dec 31, 2022 | 11.05 Mn |
| Sep 30, 2022 | 11.08 Bn |
| Mar 31, 2022 | 12.03 Mn |
| Dec 31, 2021 | 12.17 Mn |
| Dec 31, 2020 | 12.50 Mn |